Duality Biotherapeutics (HKG:9606) made a stellar trading debut in Hong Kong on Tuesday morning as its shares soared over 91% at the opening bell, defying the stock market volatility caused by the tariff war between the world's two largest economies.
The Chinese biotech firm opened at HK$181 per share, well above its initial public offering price of HK$94.60. As of 10:41 a.m., Hong Kong time, the stock traded at HK$209.60.
The company's debut takes place against a backdrop of heightened uncertainty in global equity markets, driven by escalating US-China trade tensions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。